YCBD: cbdMD Inc. Consensus Target

Corporate company logo of cbdMD Corp (YCBD)

cbdMD, Inc. promotes consumer CBD products through partnerships with wellness brands and sports organizations, as confirmed by this price chart. The technology stack relies on robotic extraction and packaging for the mass production of precise dosages. The business is currently battling stagnation in the US market by optimizing costs and updating its product range, while the indicator stands at 2.00.

cbdMD Corp - YCBD Analyst Consensus Forecast (period 07/04/2022 - 11/11/2026)
Flagship merchandise of cbdMD

Amid intense competition from eco-brands and FDA regulatory pressure on the margins of cbdMD, Inc. (YCBD), the analysts' consensus price target serves as a barometer for market expectations. This chart aggregates target valuations from investment firms, transforming fundamental risks and brand strength into specific price benchmarks, where a sharp decline in the line signals a revision of business value and the potential to acquire an undervalued asset.

Competitors of cbdMD, Inc.

HLN - Average Forecast Price|Analyst Consensus Forecast KVUE (Kenvue)|VRNA - Consensus Target|Jyong Biotech Corp - Analyst Consensus Forecast|LGND: Price Target Chart|AMRX: Analyst Consensus Forecast|Broker Consensus Forecast PRGO|Price Target Chart Alvotech SA|Liquidia Corp - Forecast Levels Chart|Analyst Consensus Forecast GLPG|ANIP (ANI Pharmaceuticals Corp) - Fair Value Consensus|Analyst Consensus Forecast MNKD (MannKind Corporation)|Analyst Consensus Forecast amphastar.com AMPH|PCRX - Price Target Chart|Fair Value Consensus SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Price Target Chart|Consensus Target Aquestive Corp|SCPH (scPharmaceuticals, Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast Tectonic|Consensus Target TNXP (Tonix Pharmaceuticals Holding Corp.)|SXTC (sxtchina.com) - Fair Value Consensus|Price Target Chart Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc (BHST) - Average Forecast Price|EXOZ: Consensus Target|Oramed Pharmaceuticals - Analyst Forecast Prices|ENTX: Analyst Consensus Forecast|MindWalk Holdings, Inc. - Fair Value Consensus|ABVC (ABVC BioPharma Inc) - Analyst Consensus Forecast|Average Forecast Price Cumberland Corp CPIX|Price Target Chart Quantum BioPharma Ltd (QNTM)|FGEN (fibrogen.com) - Fair Value Consensus|Analyst Consensus Forecast TELO (Telomir Pharmaceuticals, Inc.)|RANI - Consensus Target|Synergy CHC Corporation - Analyst Consensus Forecast|RLYB: Price Target Chart|LEXX: Analyst Consensus Forecast|Broker Consensus Forecast PULM|Price Target Chart Pheton Holdings Limited|Consensus Target Aptorum (APM)|Analyst Consensus Forecast LYRA|impactbiomedinc.com - Broker Consensus Forecast|TNF Pharmaceuticals, Inc. - Consensus Target|Fair Value Consensus PRFX|Auris Medical - Analyst Consensus Forecast|Analyst Median Target Lipella Pharmaceuticals Inc LIPO|Optinose (OPTN) - Price Target Chart|Broker Consensus Forecast PIRS|PROC (Procaps Group S.A.) - Analyst Consensus Forecast|Consensus Target petrospharma.com (PTPI)|Consensus Target QLI (Qilian International Holding)|Analyst Median Target Acelyrin Inc.|TFF Pharma - Consensus Target